GLCC calls for rapid increase in funding to address ‘worldwide scandal’ of lack of lung cancer research
New study reveals shortfall compared with other major cancers.
Lung cancer is responsible for more deaths than any other cancer (1) yet a ground-breaking study shows that it was the subject of just 5.6% of ALL global cancer research in 2013.
There were estimated to be 1.8 million new cases of lung cancer globally in 2012 (2).
‘The State of Global Lung Cancer Research’ (1), shows that research into lung cancer has increased by just 1.2% since 2004 and the relative commitment to lung cancer research has actually fallen in most countries over the past ten years.
Global under-representation in lung cancer research is confirmed in the study, carried out by a team led by Dr Ajay Aggarwal of the Institute of Cancer Policy (ICP), King’s College London, and published in the Journal of Thoracic Oncology.
Submitted by roycastle on April 29, 2015 - 10:58am
Our latest newsletter is now available. Featuring the latest in lung cancer news from around the world, this issue focuses on the findings of GLCC's global survey on awareness of the symptoms of lung cancer.
Our global interactive map, which allows lung cancer patients, clinicians and policymakers to compare statistics of the disease across the world, now offers an additional function: members can now readily export data to other formats.
Lung cancer is the biggest cancer killer in the world and there are significant variations in its incidence, mortality and survival across the globe.
The global e-atlas brings together the latest published information about lung cancer’s impact in different countries.
It also details whether each country operates a cancer plan or has implemented the World Health Organisation Framework Convention on Tobacco Control and allows users of the map to compare data from up to four countries at any one time via a dashboard system.
The export function of the GLCC e-Atlas is now live, meaning that members are able to transfer data into graphs and charts for use in presentations and documents. Members are supplied with FAQ guide to help navigate this new function.
Submitted by roycastle on September 18, 2014 - 7:45am
The GLCC has recently recognised a number of journalists for their efforts to increase awareness of lung cancer and the many issues people who are diagnosed with the illness face. Winners were selected by GLCC member organisations from all over the world.
More than one in five people are unable to name any symptoms of the world’s biggest cancer killer, according to a survey.
The research, which was carried out by Ipsos MORI on behalf of the Global Lung Cancer Coalition, investigated awareness of the symptoms of lung cancer and smoking prevalence in 21 countries.
Researchers found that across all the countries, 22% of people surveyed admitted they could not name any symptoms of the disease, which claims the lives of 1.37 million people globally every year.
The research, which surveyed over 17,000 people, also found that former smokers are slightly more likely to be aware of symptoms than current smokers or people who have never smoked.
Dr Matthew Peters, chair of The Global Lung Cancer Coalition, which is made up of 34 non-government patient organisation across the globe, said: "Patients are often diagnosed with lung cancer at a very late stage when treatment is no longer an option.
“If we can get patients diagnosed earlier, we can treat them and save lives. That is why being aware of the symptoms is so important.
“It is shocking to think that almost a quarter of people can not name any symptoms of the world’s biggest cancer killer.
In many countries Lung Cancer Awareness Month takes place in November.
It aims to achieve better outcomes for lung cancer patients and their families through:
raising public awareness of lung cancer
educating those at risk about symptoms and early presentation
signposting sources of information and support
placing lung cancer firmly on the agenda of healthcare authorities
Late stage diagnosis, poor survival outcomes and few treatment choices make lung cancer a particularly devastating and emotional disease for people to deal with.
There are many negative perceptions and stigmas surrounding the disease, which indirectly impact on funding, resources and how individuals view the condition.
Click here to view our members' websites and find out what is happening in your country this November.
Click here to download our lung cancer awareness leaflets.
Global Lung Cancer Coaltion
The GLCC is the international 'voice' of lung cancer patients. Established in 2001, the GLCC comprises 35 non-government patient organisations from Argentina, Australia, Brazil, Bulgaria, Canada, Denmark, Egypt, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK and US.